{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T10:21:02Z","timestamp":1791973262295,"version":"4.3.4"},"reference-count":186,"publisher":"SAGE Publications","issue":"2","license":[{"start":{"date-parts":[[2018,5,29]],"date-time":"2018-05-29T00:00:00Z","timestamp":1527552000000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2018,5,29]],"date-time":"2018-05-29T00:00:00Z","timestamp":1527552000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Journal of Neuromuscular Diseases"],"published-print":{"date-parts":[[2018,5,29]]},"abstract":"<jats:p>Inflammatory disorders of the skeletal muscle include polymyositis (PM), dermatomyositis (DM), (immune mediated) necrotizing myopathy (NM), overlap syndrome with myositis (overlap myositis, OM) including anti-synthetase syndrome (ASS), and inclusion body myositis (IBM). Whereas DM occurs in children and adults, all other forms of myositis mostly develop in middle aged individuals. Apart from a slowly progressive, chronic disease course in IBM, patients with myositis typically present with a subacute onset of weakness of arms and legs, often associated with pain and clearly elevated creatine kinase in the serum. PM, DM and most patients with NM and OM usually respond to immunosuppressive therapy, whereas IBM is largely refractory to treatment. The diagnosis of myositis requires careful and combinatorial assessment of (1) clinical symptoms including pattern of weakness and paraclinical tests such as MRI of the muscle and electromyography (EMG), (2) broad analysis of auto-antibodies associated with myositis, and (3) detailed histopathological work-up of a skeletal muscle biopsy. This review provides a comprehensive overview of the current classification, diagnostic pathway, treatment regimen and pathomechanistic understanding of myositis.<\/jats:p>","DOI":"10.3233\/jnd-180308","type":"journal-article","created":{"date-parts":[[2018,5,29]],"date-time":"2018-05-29T11:24:04Z","timestamp":1527593044000},"page":"109-129","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":256,"title":["Current Classification and Management of Inflammatory Myopathies"],"prefix":"10.1177","volume":"5","author":[{"given":"Jens","family":"Schmidt","sequence":"first","affiliation":[{"name":"University Medical Center G\u00f6ttingen","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2018,5,29]]},"reference":[{"key":"e_1_3_1_2_2","doi-asserted-by":"publisher","DOI":"10.1111\/cei.12194"},{"key":"e_1_3_1_3_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1402225"},{"key":"e_1_3_1_4_2","doi-asserted-by":"publisher","DOI":"10.1002\/mus.23302"},{"key":"e_1_3_1_5_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.40063"},{"key":"e_1_3_1_6_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.61.3.316"},{"key":"e_1_3_1_7_2","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2017-211868"},{"key":"e_1_3_1_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jocn.2008.01.011"},{"key":"e_1_3_1_9_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00296-012-2545-7"},{"key":"e_1_3_1_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2013.11.005"},{"key":"e_1_3_1_11_2","doi-asserted-by":"publisher","DOI":"10.1007\/s12016-015-8513-8"},{"key":"e_1_3_1_12_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.21023"},{"key":"e_1_3_1_13_2","doi-asserted-by":"publisher","DOI":"10.1097\/BOR.0000000000000329"},{"key":"e_1_3_1_14_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.22164"},{"key":"e_1_3_1_15_2","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kel161"},{"key":"e_1_3_1_16_2","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0b013e31829d08f9"},{"key":"e_1_3_1_17_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.24547"},{"key":"e_1_3_1_18_2","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2008.097162"},{"key":"e_1_3_1_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.nmd.2004.02.006"},{"key":"e_1_3_1_20_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000003568"},{"key":"e_1_3_1_21_2","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2016.00064"},{"key":"e_1_3_1_22_2","doi-asserted-by":"publisher","DOI":"10.1111\/nan.12380"},{"key":"e_1_3_1_23_2","doi-asserted-by":"publisher","DOI":"10.1097\/WCO.0000000000000376"},{"key":"e_1_3_1_24_2","doi-asserted-by":"publisher","DOI":"10.1111\/joim.12451"},{"key":"e_1_3_1_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.nmd.2015.02.014"},{"key":"e_1_3_1_26_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000004333"},{"key":"e_1_3_1_27_2","doi-asserted-by":"publisher","DOI":"10.1212\/01.wnl.0000277527.69388.fe"},{"key":"e_1_3_1_28_2","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.141443"},{"key":"e_1_3_1_29_2","doi-asserted-by":"publisher","DOI":"10.1007\/s12016-015-8510-y"},{"key":"e_1_3_1_30_2","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.73.4.420"},{"key":"e_1_3_1_31_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780330908"},{"key":"e_1_3_1_32_2","doi-asserted-by":"publisher","DOI":"10.1186\/s13023-015-0277-y"},{"key":"e_1_3_1_33_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.27572"},{"key":"e_1_3_1_34_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.30156"},{"key":"e_1_3_1_35_2","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000000028"},{"key":"e_1_3_1_36_2","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/aww054"},{"key":"e_1_3_1_37_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2990.2012.01302.x"},{"key":"e_1_3_1_38_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.nmd.2012.09.001"},{"key":"e_1_3_1_39_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.md.0000173991.74008.b0"},{"key":"e_1_3_1_40_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2014.03.004"},{"key":"e_1_3_1_41_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2012.06.006"},{"key":"e_1_3_1_42_2","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2012-201800"},{"key":"e_1_3_1_43_2","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0b013e31824d9cec"},{"key":"e_1_3_1_44_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2011.09.008"},{"key":"e_1_3_1_45_2","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awv192"},{"key":"e_1_3_1_46_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000001422"},{"key":"e_1_3_1_47_2","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/aww125"},{"key":"e_1_3_1_48_2","doi-asserted-by":"publisher","DOI":"10.1097\/BOR.0000000000000436"},{"key":"e_1_3_1_49_2","doi-asserted-by":"publisher","DOI":"10.3233\/JND-150138"},{"key":"e_1_3_1_50_2","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awr217"},{"key":"e_1_3_1_51_2","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awr213"},{"key":"e_1_3_1_52_2","doi-asserted-by":"publisher","DOI":"10.1002\/ana.23822"},{"key":"e_1_3_1_53_2","doi-asserted-by":"publisher","DOI":"10.1002\/ana.23840"},{"key":"e_1_3_1_54_2","doi-asserted-by":"publisher","DOI":"10.1002\/acr.22600"},{"key":"e_1_3_1_55_2","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2014-206691"},{"key":"e_1_3_1_56_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cca.2017.07.002"},{"key":"e_1_3_1_57_2","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2014-310008"},{"key":"e_1_3_1_58_2","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2016-210282"},{"key":"e_1_3_1_59_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000003337"},{"key":"e_1_3_1_60_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.nmd.2013.08.007"},{"issue":"3","key":"e_1_3_1_61_2","first-page":"208","article-title":"Malignancy in myositis","volume":"13","author":"Zahr ZA","year":"2011","unstructured":"ZahrZA, BaerANMalignancy in myositis. Curr Rheumatol Re. 2011;13(3):208\u201315.","journal-title":"Curr Rheumatol Re"},{"key":"e_1_3_1_62_2","doi-asserted-by":"publisher","DOI":"10.1097\/BOR.0b013e32833f1075"},{"issue":"2","key":"e_1_3_1_63_2","first-page":"131","article-title":"Risk of Malignancy in Dermatomyositis and Polymyositis","volume":"21","author":"Qiang JK","year":"2017","unstructured":"QiangJK, KimWB, BaibergenovaA, AlhusayenRRisk of Malignancy in Dermatomyositis and Polymyositis. J CutanMed Surg. 2017;21(2):131\u20136.","journal-title":"J CutanMed Surg"},{"key":"e_1_3_1_64_2","doi-asserted-by":"publisher","DOI":"10.1007\/s40257-015-0120-1"},{"key":"e_1_3_1_65_2","doi-asserted-by":"publisher","DOI":"10.1183\/16000617.00002015"},{"key":"e_1_3_1_66_2","doi-asserted-by":"publisher","DOI":"10.1097\/BOR.0000000000000104"},{"key":"e_1_3_1_67_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.chest.2016.04.007"},{"key":"e_1_3_1_68_2","doi-asserted-by":"publisher","DOI":"10.1136\/rmdopen-2016-000291"},{"key":"e_1_3_1_69_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.rdc.2017.09.006"},{"key":"e_1_3_1_70_2","first-page":"4831053","article-title":"Scleroderma-like renal crisis in a patient with anti-threonyl-tRNA synthetase-associated antisynthetase syndrome","author":"Hermans MAW","year":"2018","unstructured":"HermansMAW, MiedemaJR, VerdijkRM, van DaelePLAScleroderma-like renal crisis in a patient with anti-threonyl-tRNA synthetase-associated antisynthetase syndrome. Rheumatology (Oxford). 2018)4831053.","journal-title":"Rheumatology (Oxford)"},{"key":"e_1_3_1_71_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.40320"},{"key":"e_1_3_1_72_2","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2017-211468"},{"key":"e_1_3_1_73_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM197502132920706"},{"issue":"4","key":"e_1_3_1_74_2","first-page":"668","article-title":"Classification criteria for polymyositis and dermatomyositis","volume":"22","author":"Tanimoto K","year":"1995","unstructured":"TanimotoK, NakanoK, KanoS, MoriS, UekiH, NishitaniH, et al. Classification criteria for polymyositis and dermatomyositis. JRheumatol. 1995;22(4):668\u201374.","journal-title":"JRheumatol"},{"key":"e_1_3_1_75_2","doi-asserted-by":"publisher","DOI":"10.1097\/00002281-199711000-00008"},{"key":"e_1_3_1_76_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(03)14368-1"},{"key":"e_1_3_1_77_2","doi-asserted-by":"crossref","unstructured":"HocevarA RotarZ KroselM CucnikS TomsicMPerformance of the 2017 European League Against Rheumatism\/American College of Rheumatology classification criteria for adult and juvenile idiopathic inflammatory myopathies in clinical practice. Ann Rheum Dis. 2017)annrheumdis212774.","DOI":"10.1136\/annrheumdis-2017-212774"},{"key":"e_1_3_1_78_2","doi-asserted-by":"crossref","unstructured":"LundbergIE BottaiM TjarnlundAResponse to: \u2018Performance of the 2017 European League Against Rheumatism\/American College of Rheumatology classification criteria for adult and juvenile idiopathic inflammatory myopathies in clinical practice\u2019 by Hocevar et al. Ann Rheum Dis. 2018)annrheumdis212786.","DOI":"10.1136\/annrheumdis-2017-212786"},{"key":"e_1_3_1_79_2","doi-asserted-by":"crossref","unstructured":"LundbergIE TjarnlundAResponse to: \u20192017 EULAR\/ACR classification criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups: Little emphasis on autoantibodies why?\u2019 by Malaviya. Ann Rheum Dis.. 2017;annrheumdis212709.","DOI":"10.1136\/annrheumdis-2017-212709"},{"key":"e_1_3_1_80_2","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410380504"},{"key":"e_1_3_1_81_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.55.9.1385"},{"key":"e_1_3_1_82_2","doi-asserted-by":"publisher","DOI":"10.1038\/ncpneuro0261"},{"key":"e_1_3_1_83_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000000642"},{"key":"e_1_3_1_84_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2016.11.001"},{"key":"e_1_3_1_85_2","doi-asserted-by":"publisher","DOI":"10.1097\/BOR.0000000000000326"},{"key":"e_1_3_1_86_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0184059"},{"issue":"4","key":"e_1_3_1_87_2","first-page":"302","article-title":"Ultrasound in the evaluation of the inflammatory myopathies","volume":"11","author":"Adler RS","year":"2009","unstructured":"AdlerRS, GarofaloGUltrasound in the evaluation of the inflammatory myopathies. Curr Rheumatol Re. 2009;11(4):302\u20138.","journal-title":"Curr Rheumatol Re"},{"key":"e_1_3_1_88_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1749-6632.2009.04390.x"},{"key":"e_1_3_1_89_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0181069"},{"key":"e_1_3_1_90_2","doi-asserted-by":"publisher","DOI":"10.1177\/2058460116668216"},{"key":"e_1_3_1_91_2","doi-asserted-by":"publisher","DOI":"10.3109\/03009742.2013.868509"},{"key":"e_1_3_1_92_2","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2012-202915"},{"key":"e_1_3_1_93_2","doi-asserted-by":"publisher","DOI":"10.2214\/AJR.17.17849"},{"key":"e_1_3_1_94_2","doi-asserted-by":"publisher","DOI":"10.1002\/mus.24661"},{"key":"e_1_3_1_95_2","doi-asserted-by":"publisher","DOI":"10.1097\/BOR.0000000000000435"},{"key":"e_1_3_1_96_2","doi-asserted-by":"publisher","DOI":"10.3390\/ijms160818683"},{"key":"e_1_3_1_97_2","doi-asserted-by":"publisher","DOI":"10.1007\/s12016-016-8527-x"},{"key":"e_1_3_1_98_2","doi-asserted-by":"publisher","DOI":"10.1517\/17530051003713499"},{"key":"e_1_3_1_99_2","doi-asserted-by":"publisher","DOI":"10.1097\/BOR.0000000000000328"},{"key":"e_1_3_1_100_2","doi-asserted-by":"publisher","DOI":"10.1080\/15321819.2017.1298525"},{"key":"e_1_3_1_101_2","doi-asserted-by":"publisher","DOI":"10.1097\/BOR.0000000000000337"},{"key":"e_1_3_1_102_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2016.09.019"},{"key":"e_1_3_1_103_2","doi-asserted-by":"publisher","DOI":"10.1002\/acn3.419"},{"key":"e_1_3_1_104_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI118749"},{"key":"e_1_3_1_105_2","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awh148"},{"key":"e_1_3_1_106_2","doi-asserted-by":"publisher","DOI":"10.1002\/eji.1830241114"},{"key":"e_1_3_1_107_2","doi-asserted-by":"publisher","DOI":"10.1002\/ana.20293"},{"issue":"10","key":"e_1_3_1_108_2","first-page":"2030","article-title":"Clonal restriction of T-cellreceptor expression by infiltrating lymphocytes in inclusion bodymyositis persists over time","volume":"123","author":"Amemiya K","year":"2000","unstructured":"AmemiyaK, GrangerRP, DalakasMCClonal restriction of T-cellreceptor expression by infiltrating lymphocytes in inclusion bodymyositis persists over time. Studies in repeated muscle biopsies.Brain. 2000;123(Pt 10):2030\u20139.","journal-title":"Studies in repeated muscle biopsies.Brain"},{"key":"e_1_3_1_109_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0236183100"},{"key":"e_1_3_1_110_2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.178.1.547"},{"key":"e_1_3_1_111_2","doi-asserted-by":"publisher","DOI":"10.1212\/01.wnl.0000187124.92826.20"},{"key":"e_1_3_1_112_2","doi-asserted-by":"publisher","DOI":"10.1097\/BOR.0b013e3283317b31"},{"key":"e_1_3_1_113_2","doi-asserted-by":"publisher","DOI":"10.1111\/cei.12445"},{"key":"e_1_3_1_114_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.27465"},{"key":"e_1_3_1_115_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0b013e31821f440a"},{"key":"e_1_3_1_116_2","doi-asserted-by":"publisher","DOI":"10.1186\/ar3791"},{"key":"e_1_3_1_117_2","doi-asserted-by":"publisher","DOI":"10.1097\/BOR.0000000000000212"},{"key":"e_1_3_1_118_2","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awn053"},{"key":"e_1_3_1_119_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.expneurol.2015.05.023"},{"key":"e_1_3_1_120_2","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/aws046"},{"key":"e_1_3_1_121_2","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.2009.174276"},{"issue":"7","key":"e_1_3_1_122_2","first-page":"470","article-title":"Genome-wide association study identifies HLA 8","volume":"16","author":"Miller FW","year":"2015","unstructured":"MillerFW, ChenW, O\u2019HanlonTP, CooperRG, VencovskyJ, RiderLG, et al. Genome-wide association study identifies HLA 8. 1 ancestral haplotype alleles as major genetic risk factors for myositis phenotypes. Genes Immun. 2015;16(7):470\u201380.","journal-title":"1 ancestral haplotype alleles as major genetic risk factors for myositis phenotypes. Genes Immun"},{"key":"e_1_3_1_123_2","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2015-208119"},{"key":"e_1_3_1_124_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.40045"},{"key":"e_1_3_1_125_2","doi-asserted-by":"publisher","DOI":"10.1002\/ana.21115"},{"key":"e_1_3_1_126_2","doi-asserted-by":"publisher","DOI":"10.1002\/ana.24847"},{"key":"e_1_3_1_127_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780341108"},{"key":"e_1_3_1_128_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.37985"},{"key":"e_1_3_1_129_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.24702"},{"key":"e_1_3_1_130_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000002291"},{"key":"e_1_3_1_131_2","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4419-8216-2_6"},{"key":"e_1_3_1_132_2","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kex162"},{"key":"e_1_3_1_133_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11926-012-0249-3"},{"key":"e_1_3_1_134_2","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2005.045690"},{"key":"e_1_3_1_135_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-014-7313-z"},{"key":"e_1_3_1_136_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00313897"},{"key":"e_1_3_1_137_2","doi-asserted-by":"publisher","DOI":"10.1159\/000338474"},{"key":"e_1_3_1_138_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.nmd.2010.03.011"},{"issue":"8","key":"e_1_3_1_139_2","first-page":"CD003643","article-title":"Immunosuppressant and immunomodulatory treatment for dermatomyositis and polymyositis","author":"Gordon PA","year":"2012","unstructured":"GordonPA, WinerJB, HoogendijkJE, ChoyEHImmunosuppressant and immunomodulatory treatment for dermatomyositis and polymyositis. Cochrane Database Syst Rev.. 2012)8CD003643.","journal-title":"Cochrane Database Syst Rev."},{"key":"e_1_3_1_140_2","doi-asserted-by":"publisher","DOI":"10.1186\/s13023-015-0332-8"},{"key":"e_1_3_1_141_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2016.07.014"},{"key":"e_1_3_1_142_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.37754"},{"key":"e_1_3_1_143_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.37758"},{"key":"e_1_3_1_144_2","doi-asserted-by":"publisher","DOI":"10.1002\/acr.22920"},{"key":"e_1_3_1_145_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.34673"},{"key":"e_1_3_1_146_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199312303292704"},{"key":"e_1_3_1_147_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2017.07.016"},{"key":"e_1_3_1_148_2","doi-asserted-by":"publisher","DOI":"10.1111\/joim.12481"},{"key":"e_1_3_1_149_2","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awp104"},{"key":"e_1_3_1_150_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12883-016-0568-5"},{"key":"e_1_3_1_151_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.48.3.712"},{"key":"e_1_3_1_152_2","doi-asserted-by":"publisher","DOI":"10.1007\/s004150050005"},{"key":"e_1_3_1_153_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.56.3.323"},{"issue":"6","key":"e_1_3_1_154_2","first-page":"838","article-title":"Long-term follow-up of sporadic inclusion body myositis treated with intravenous immunoglobul A retrospective study of 16 patients","volume":"30","author":"Dobloug C","year":"2012","unstructured":"DoblougC, Walle-HansenR, GranJT, MolbergOLong-term follow-up of sporadic inclusion body myositis treated with intravenous immunoglobul A retrospective study of 16 patientsClin Exp Rheumatol. 2012;30(6):838\u201342.","journal-title":"Clin Exp Rheumatol"},{"key":"e_1_3_1_155_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.10053"},{"key":"e_1_3_1_156_2","doi-asserted-by":"publisher","DOI":"10.1159\/000441490"},{"key":"e_1_3_1_157_2","doi-asserted-by":"publisher","DOI":"10.1517\/21678707.2014.966688"},{"key":"e_1_3_1_158_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11926-013-0329-z"},{"key":"e_1_3_1_159_2","doi-asserted-by":"publisher","DOI":"10.1002\/mus.25036"},{"key":"e_1_3_1_160_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-009-5229-9"},{"key":"e_1_3_1_161_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00455-011-9384-7"},{"key":"e_1_3_1_162_2","doi-asserted-by":"publisher","DOI":"10.1097\/PHM.0b013e31818a50e2"},{"key":"e_1_3_1_163_2","doi-asserted-by":"publisher","DOI":"10.1155\/2004\/360537"},{"key":"e_1_3_1_164_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2017.07.031"},{"key":"e_1_3_1_165_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10072-016-2586-x"},{"key":"e_1_3_1_166_2","doi-asserted-by":"publisher","DOI":"10.1097\/BOR.0000000000000433"},{"key":"e_1_3_1_167_2","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/40.11.1262"},{"issue":"11","key":"e_1_3_1_168_2","first-page":"S118","article-title":"Measures of adult and juvenile dermatomyositis, polymyositis, and inclusion body myositis: Physician and Patient\/Parent Global Activity, Manual Muscle Testing (MMT), Health Assessment Questionnaire (HAQ)\/Childhood Health Assessment Questionnaire (C-HAQ), Childhood Myositis Assessment Scale (CMAS), Myositis Disease Activity Assessment Tool (MDAAT), Disease Activity Score (DAS), Short Form 36 (SF-36), Child Health Questionnaire (CHQ), physician global damage, Myositis Damage Index (MDI), Quantitative Muscle Testing (QMT), Myositis Functional Index-2 (FI-2), Myositis Activities Profile (MAP), Inclusion Body Myositis Functional Rating Scale (IBMFRS), Cutaneous Dermatomyositis Disease Area and Severity Index (CDASI), Cutaneous Assessment Tool (CAT), Dermatomyositis Skin Severity Index (DSSI), Skindex, and Dermatology Life Quality Index (DLQI)","volume":"63","author":"Rider LG","year":"2011","unstructured":"RiderLG, WerthVP, HuberAM, AlexandersonH, RaoAP, RupertoN, et al. Measures of adult and juvenile dermatomyositis, polymyositis, and inclusion body myositis: Physician and Patient\/Parent Global Activity, Manual Muscle Testing (MMT), Health Assessment Questionnaire (HAQ)\/Childhood Health Assessment Questionnaire (C-HAQ), Childhood Myositis Assessment Scale (CMAS), Myositis Disease Activity Assessment Tool (MDAAT), Disease Activity Score (DAS), Short Form 36 (SF-36), Child Health Questionnaire (CHQ), physician global damage, Myositis Damage Index (MDI), Quantitative Muscle Testing (QMT), Myositis Functional Index-2 (FI-2), Myositis Activities Profile (MAP), Inclusion Body Myositis Functional Rating Scale (IBMFRS), Cutaneous Dermatomyositis Disease Area and Severity Index (CDASI), Cutaneous Assessment Tool (CAT), Dermatomyositis Skin Severity Index (DSSI), Skindex, and Dermatology Life Quality Index (DLQI). Arthritis Care Res (Hoboken). 2011;63(Suppl 11):S118\u2013S157.","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"e_1_3_1_169_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.24904"},{"key":"e_1_3_1_170_2","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2017-211400"},{"key":"e_1_3_1_171_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.40064"},{"key":"e_1_3_1_172_2","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2017-211401"},{"key":"e_1_3_1_173_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.40060"},{"key":"e_1_3_1_174_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.21715"},{"key":"e_1_3_1_175_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.nmd.2013.11.012"},{"issue":"17","key":"e_1_3_1_176_2","first-page":"32578","article-title":"Cutaneous dermatomyositis disease course followed over time using the Cutaneous Dermatomyositis Disease Area and Severity Index (CDASI)","author":"Chansky PB","year":"2017","unstructured":"ChanskyPB, OlazagastiJM, FengR, WerthVPCutaneous dermatomyositis disease course followed over time using the Cutaneous Dermatomyositis Disease Area and Severity Index (CDASI). J Am Acad Dermatol. 2017;pii:S0190-9622(17):32578\u20131.","journal-title":"J Am Acad Dermatol"},{"key":"e_1_3_1_177_2","doi-asserted-by":"publisher","DOI":"10.1002\/mus.20958"},{"key":"e_1_3_1_178_2","doi-asserted-by":"publisher","DOI":"10.1002\/mus.25079"},{"key":"e_1_3_1_179_2","doi-asserted-by":"publisher","DOI":"10.1002\/acr.22473"},{"key":"e_1_3_1_180_2","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.161252"},{"key":"e_1_3_1_181_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5085(00)70137-5"},{"key":"e_1_3_1_182_2","doi-asserted-by":"publisher","DOI":"10.1097\/BOR.0000000000000430"},{"key":"e_1_3_1_183_2","first-page":"179180","article-title":"New onset of dermatomyositis\/polymyositis during anti-TNF-alpha therapies: A systematic literature review","author":"Brunasso AM","year":"2014","unstructured":"BrunassoAM, AbererW, MassoneCNew onset of dermatomyositis\/polymyositis during anti-TNF-alpha therapies: A systematic literature review. ScientificWorldJournal. 2014;179180.","journal-title":"ScientificWorldJournal"},{"key":"e_1_3_1_184_2","doi-asserted-by":"publisher","DOI":"10.1002\/ana.22477"},{"key":"e_1_3_1_185_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000001070"},{"issue":"10","key":"e_1_3_1_186_2","article-title":"Rapamycin Vs. Placebo for the Treatment of Inclusion Body Myositis: Improvement of the 6 Min Walking Distance, a Functional Scale, the FVC and Muscle Quantitative MRI","volume":"69","author":"Benveniste O","year":"2018","unstructured":"BenvenisteO, HogrelJY, AnnoussamyM, BachassonD, RigoletA, ServaisL, et al. Rapamycin Vs. Placebo for the Treatment of Inclusion Body Myositis: Improvement of the 6 Min Walking Distance, a Functional Scale, the FVC and Muscle Quantitative MRI. Arthritis Rheumatol.. 2018;69(Suppl 10)(Abstract).","journal-title":"Arthritis Rheumatol."},{"key":"e_1_3_1_187_2","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aad4583"}],"container-title":["Journal of Neuromuscular Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.3233\/JND-180308","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.3233\/JND-180308","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.3233\/JND-180308","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T23:53:29Z","timestamp":1777506809000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.3233\/JND-180308"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5,29]]},"references-count":186,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,5,29]]}},"alternative-id":["10.3233\/JND-180308"],"URL":"https:\/\/doi.org\/10.3233\/jnd-180308","relation":{},"ISSN":["2214-3599","2214-3602"],"issn-type":[{"value":"2214-3599","type":"print"},{"value":"2214-3602","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,5,29]]}}}